Visualitzant O - Articles científics per títol

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy

Muñoz de Nova, Jose Luis; Hernando Cubero, Jorge; Sampedro-Núñez, Miguel; Vázquez Benítez, Greissy Tibisay; Triviño-Ibañez, Eva-Maria; Del Olmo García, Maria Isabel; Barriuso, J.; Martin-Perez, Elena; Capdevila Castillon, Jaume (Baishideng Publishing Group, 2022-04-07)

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; Fizazi, Karim; James, Nicholas D.; Mateo Valderrama, Joaquim; de Bono, Johann S (Elsevier, 2023-03)

Managing venous thrombosis in a pediatric patient with short bowel and congenital nephrotic syndromes: a case report emphasizing rivaroxaban level monitoring

Artaza, Gonzalo; Hernández Mata, Carlos F.; Pérez Beltrán, Víctor; Cabello Ruiz, Vanessa; Bosch Schips, Marc; Olivera, Pável E. (Frontiers Media, 2024-04-03)

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Steeghs, Neeltje; Hansen, Aaron; Garralda Cabanas, Elena; Park, Haeseong; Strauss, James; Hanna, Glenn (Wiley, 2022-11)

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe; Im, Seock-Ah (American Society of Clinical Oncology, 2023-01-10)

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps

Carrillo Rodriguez, Paula; Selheim, Frode; Hernandez-Valladares, Maria del Carmen (MDPI, 2023-01-16)

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion

Benito Martin, Alberto; Nogues, Laura; Hergueta-Redondo, Marta; Castellano-Sanz, Elena; Garvin, Eduardo; Cioffi, Michele; Villanueva Cardús, Josep (Wiley, 2023-02)

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

Janjigian, Yelena; Van Cutsem, Eric; Muro, Kei; Al-Batran, Salah-Eddin; Hyung, Woo Jin; Tabernero Caturla, Josep; Wainberg, Zev (Future Medicine, 2022-06)

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Czajka-Francuz, Paulina; Prendes, Maria J.; Mankan, Arun K; Pabla, Sarabjot; Ramkissoon, Shakti; Quintana, Angela; Peiró, Sandra (Frontiers Media, 2023-06-22)

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

Wright, Sarah Christine Elisabeth; Vasilevski, Natali; Serra Elizalde, Violeta; Rodon Ahnert, Jordi; Eichhorn, Pieter Johan Adam (MDPI, 2021-04)

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer

Wright, Alan J.; D’Santos, Paula; Hu, De-en; Hesketh, Richard L.; Lubling, Yaniv; Antunes de Melo Oliveira, Ana Mafalda; Ros, Susana (Cell Press, 2020-10-12)

Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

LA SALVIA, ANNA; Lens-Pardo, Alberto; López-López, Angel; Carretero-Puche, Carlos; Benavent, Marta; Capdevila Castillon, Jaume (Oxford University Press, 2024-01)

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation

Gerratana, Lorenzo; Pierga, Jean-Yves; Reuben, James; Davis, Andrew; Wehbe, Firas H.; Dirix, Luc; Mattos Arruda, Leticia de (Oxford University Press, 2022-07)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Managing venous thrombosis in a pediatric patient with short bowel and congenital nephrotic syndromes: a case report emphasizing rivaroxaban level monitoring

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer

Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy

Microsurgery in pediatric upper limb reconstructions: An overview

MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer

miR-203 drives breast cancer cell differentiation

miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy ﻿

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 ﻿

Managing venous thrombosis in a pediatric patient with short bowel and congenital nephrotic syndromes: a case report emphasizing rivaroxaban level monitoring ﻿

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development ﻿

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial ﻿

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps ﻿

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion ﻿

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer ﻿

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy ﻿

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity ﻿

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer ﻿

Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival ﻿

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials ﻿

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients ﻿

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy ﻿

Microsurgery in pediatric upper limb reconstructions: An overview ﻿

MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer ﻿

miR-203 drives breast cancer cell differentiation ﻿

miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs ﻿

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Managing venous thrombosis in a pediatric patient with short bowel and congenital nephrotic syndromes: a case report emphasizing rivaroxaban level monitoring

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer

Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy

Microsurgery in pediatric upper limb reconstructions: An overview

MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer

miR-203 drives breast cancer cell differentiation

miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation